Ipamorelin
All information below is drawn from preclinical research literature and is provided for educational and informational purposes only. It does not constitute medical advice, imply therapeutic outcomes, or endorse any specific application.
Chemical Identification
Property
Value
Overview
General Research Context
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2Nal-D-Phe-Lys-NH2) classified as a growth hormone secretagogue (GHS). In laboratory settings, it is studied for its interactions with the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in preclinical models.
The compound is examined in receptor selectivity studies and binding affinity assays to characterize its interaction profile with the GHS-R1a receptor relative to other members of the secretagogue class.
Areas of Investigation
Observed Interactions and Background
In receptor binding assays, Ipamorelin has been characterized for its selective interaction with the GHS-R1a receptor. Published preclinical data has examined the compound's binding profile in comparison to other secretagogue compounds, noting differences in receptor selectivity patterns.
Animal model studies have examined Ipamorelin in the context of growth hormone release kinetics and pituitary signaling markers. Researchers have observed that the compound's receptor interaction profile differs from that of endogenous ghrelin in certain assay systems. These observations are derived from preclinical research settings.
Laboratory Notes
Synthesis and Stability Notes
Due to its very small molecular footprint, Ipamorelin is easily and inexpensively synthesized in high purity (>98%) via standard SPPS. The unique sequence utilizes non-natural amino acids, notably α-aminoisobutyric acid (Aib) and D-2-naphthylalanine (D-2-Nal), to forcibly achieve its highly specific, rigid receptor-docking geometry. The C-terminus is intentionally amidated (NH2) to increase the molecule's chemical stability. In the lab, it manifests as a white to off-white solid powder with a documented melting point of 144-147°C.
Disclaimer: All information provided herein is strictly for educational and laboratory research reference purposes only. Saga does not endorse, interpret, or evaluate these preclinical studies for any specific in vivo application or human therapeutic outcome.